189 related articles for article (PubMed ID: 28684545)
1. Macrolides protect against
Fan LC; Lin JL; Yang JW; Mao B; Lu HW; Ge BX; Choi AMK; Xu JF
Am J Physiol Lung Cell Mol Physiol; 2017 Oct; 313(4):L677-L686. PubMed ID: 28684545
[TBL] [Abstract][Full Text] [Related]
2. Pseudomonas aeruginosa type-3 secretion system dampens host defense by exploiting the NLRC4-coupled inflammasome.
Faure E; Mear JB; Faure K; Normand S; Couturier-Maillard A; Grandjean T; Balloy V; Ryffel B; Dessein R; Chignard M; Uyttenhove C; Guery B; Gosset P; Chamaillard M; Kipnis E
Am J Respir Crit Care Med; 2014 Apr; 189(7):799-811. PubMed ID: 24555512
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study.
Keir HR; Shoemark A; Dicker AJ; Perea L; Pollock J; Giam YH; Suarez-Cuartin G; Crichton ML; Lonergan M; Oriano M; Cant E; Einarsson GG; Furrie E; Elborn JS; Fong CJ; Finch S; Rogers GB; Blasi F; Sibila O; Aliberti S; Simpson JL; Huang JTJ; Chalmers JD
Lancet Respir Med; 2021 Aug; 9(8):873-884. PubMed ID: 33609487
[TBL] [Abstract][Full Text] [Related]
4. Clinical Isolates of Pseudomonas aeruginosa from Chronically Infected Cystic Fibrosis Patients Fail To Activate the Inflammasome during Both Stable Infection and Pulmonary Exacerbation.
Huus KE; Joseph J; Zhang L; Wong A; Aaron SD; Mah TF; Sad S
J Immunol; 2016 Apr; 196(7):3097-108. PubMed ID: 26895832
[TBL] [Abstract][Full Text] [Related]
5. Azithromycin potentiates avian IgY effect against Pseudomonas aeruginosa in a murine pulmonary infection model.
Thomsen K; Christophersen L; Lerche CJ; Holmgaard DB; Calum H; Høiby N; Moser C
Int J Antimicrob Agents; 2021 Jan; 57(1):106213. PubMed ID: 33256950
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the Injectisome and Flagellar Type III Secretion Systems by INP1855 Impairs Pseudomonas aeruginosa Pathogenicity and Inflammasome Activation.
Anantharajah A; Faure E; Buyck JM; Sundin C; Lindmark T; Mecsas J; Yahr TL; Tulkens PM; Mingeot-Leclercq MP; Guery B; Van Bambeke F
J Infect Dis; 2016 Oct; 214(7):1105-16. PubMed ID: 27412581
[TBL] [Abstract][Full Text] [Related]
7. Azithromycin inhibits IL-1 secretion and non-canonical inflammasome activation.
Gualdoni GA; Lingscheid T; Schmetterer KG; Hennig A; Steinberger P; Zlabinger GJ
Sci Rep; 2015 Jul; 5():12016. PubMed ID: 26152605
[TBL] [Abstract][Full Text] [Related]
8. Azithromycin Modulates 3',5'-cyclic Diguanylic Acid Signaling in Pseudomonas aeruginosa.
Kimura S; Mori N; Kai T; Ishii Y; Yamaguchi K; Tateda K
J Infect Chemother; 2017 Aug; 23(8):550-555. PubMed ID: 28579350
[TBL] [Abstract][Full Text] [Related]
9. Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P. aeruginosa lung infection in Cftr(-/-) mice.
Hoffmann N; Lee B; Hentzer M; Rasmussen TB; Song Z; Johansen HK; Givskov M; Høiby N
Antimicrob Agents Chemother; 2007 Oct; 51(10):3677-87. PubMed ID: 17620382
[TBL] [Abstract][Full Text] [Related]
10. [Effects of azithromycin on the virulence of Pseudomonas aeruginosa].
Reinert P
Pathol Biol (Paris); 1995 Jun; 43(6):551-3. PubMed ID: 8539081
[TBL] [Abstract][Full Text] [Related]
11. Iraqi propolis increases degradation of IL-1β and NLRC4 by autophagy following Pseudomonas aeruginosa infection.
Jabir MS; Sulaiman GM; Taqi ZJ; Li D
Microbes Infect; 2018 Feb; 20(2):89-100. PubMed ID: 29104144
[TBL] [Abstract][Full Text] [Related]
12. Azithromycin inhibits the production of MUC5AC in the airway mucosa of patients with bronchiectasis induced by Pseudomonas aeruginosa.
Wang J; Xu L; Lv Y; Sun L
Pak J Pharm Sci; 2021 May; 34(3(Special)):1179-1185. PubMed ID: 34602387
[TBL] [Abstract][Full Text] [Related]
13. Increased susceptibility of Pseudomonas aeruginosa to macrolides and ketolides in eukaryotic cell culture media and biological fluids due to decreased expression of oprM and increased outer-membrane permeability.
Buyck JM; Plésiat P; Traore H; Vanderbist F; Tulkens PM; Van Bambeke F
Clin Infect Dis; 2012 Aug; 55(4):534-42. PubMed ID: 22573850
[TBL] [Abstract][Full Text] [Related]
14. Synergistic Activity of Berberine with Azithromycin against Pseudomonas Aeruginosa Isolated from Patients with Cystic Fibrosis of Lung In Vitro and In Vivo.
Li Y; Huang J; Li L; Liu L
Cell Physiol Biochem; 2017; 42(4):1657-1669. PubMed ID: 28738346
[TBL] [Abstract][Full Text] [Related]
15. Azithromycin is the answer in paediatric respiratory medicine, but what was the question?
Bush A
Paediatr Respir Rev; 2020 Apr; 34():67-74. PubMed ID: 31629643
[TBL] [Abstract][Full Text] [Related]
16. Regulatory effects of macrolides on bacterial virulence: potential role as quorum-sensing inhibitors.
Tateda K; Standiford TJ; Pechere JC; Yamaguchi K
Curr Pharm Des; 2004; 10(25):3055-65. PubMed ID: 15544497
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.
Bala A; Kumar R; Harjai K
J Med Microbiol; 2011 Mar; 60(Pt 3):300-306. PubMed ID: 21127154
[TBL] [Abstract][Full Text] [Related]
18. Potential of macrolide antibiotics to inhibit protein synthesis of Pseudomonas aeruginosa: suppression of virulence factors and stress response.
Tateda K; Ishii Y; Matsumoto T; Kobayashi T; Miyazaki S; Yamaguchi K
J Infect Chemother; 2000 Mar; 6(1):1-7. PubMed ID: 11810524
[TBL] [Abstract][Full Text] [Related]
19. Direct evidence for antipseudomonal activity of macrolides: exposure-dependent bactericidal activity and inhibition of protein synthesis by erythromycin, clarithromycin, and azithromycin.
Tateda K; Ishii Y; Matsumoto T; Furuya N; Nagashima M; Matsunaga T; Ohno A; Miyazaki S; Yamaguchi K
Antimicrob Agents Chemother; 1996 Oct; 40(10):2271-5. PubMed ID: 8891128
[TBL] [Abstract][Full Text] [Related]
20. Azithromycin analogue CSY0073 attenuates lung inflammation induced by LPS challenge.
Balloy V; Deveaux A; Lebeaux D; Tabary O; le Rouzic P; Ghigo JM; Busson PF; Boëlle PY; Guez JG; Hahn U; Clement A; Chignard M; Corvol H; Burnet M; Guillot L
Br J Pharmacol; 2014 Apr; 171(7):1783-94. PubMed ID: 24417187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
